Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock ...
Add Yahoo as a preferred source to see more of our stories on Google. Most people who've had a heart attack—or who fear having one—focus on surviving the cardiovascular event itself. But what happens ...
CNW/ -- (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, ...
Centers with multidisciplinary teams created to rapidly respond to cardiogenic shock are more likely to use invasive hemodynamic monitoring and advanced mechanical circulatory support (MCS), but less ...
More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...
Women with heart failure–related cardiogenic shock have worse outcomes and more vascular complications than men, a new analysis of registry data shows. "These data identify the need for us to continue ...
Numerous knowledge gaps exist regarding the care of female patients with cardiogenic shock, often because they have been consistently underrepresented in clinical trials, according to a new consensus ...
LAS VEGAS--(BUSINESS WIRE)--Abiomed (NASDAQ:ABMD) announces that new data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients from 35 ...
Please provide your email address to receive an email when new articles are posted on . “The women and men in our study had similar clinical characteristics when they developed cardiogenic shock after ...
CHICAGO -- Unexpectedly, early extracorporeal membrane oxygenation (ECMO) did not help outcomes in severe or rapidly progressing cardiogenic shock, the ECMO-CS randomized trial found. What appeared to ...
SUPPORT II (SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)) is a prospective, randomized controlled study designed to assess the safety and efficacy of the c ...